Scleroderma Diagnostics and Therapeutics Market Projected to Register 10.3% CAGR Through 2024
The global market for scleroderma diagnostics and therapeutics features a fragmented marketplace owing to the presence of several pharmaceutical companies market with different drugs for the multiple complex symptoms experienced by a scleroderma patient, observes Transparency Market Research (TMR) in a recent report.
View full press release